People with chronic Hepatitis C do not have any symptoms. However, if a person has been infected for many years, his or her liver may be damaged. - CBCD.net
Rochester, NY (PRWEB) March 18, 2014
In the United States, almost 3 million people are chronically infected with Hepatitis C (HCV). As stated by Dr. Scott D. Holmberg, “This number should be considered a minimum estimate for those infected in the U.S. (1).” Moreover, “Hepatitis C has a severe impact…especially (on) baby boomers (those born from 1945 through 1965)… Baby boomers represent about 81 percent of chronically infected people (1).”
A study found that “prevalence of HCV infection was one percent among people ages six and older, which corresponds to 2.7 million people across the U.S. Even more people had antibodies against the virus in their blood, suggesting they had been exposed to it in the past. People with HCV were more likely than those who had never been infected to be in their 40s or 50s, male and black and to have been born in the U.S., the authors reported in the Annals of Internal Medicine. They were less likely be well-off or to have education past high school (1).”
“Hepatitis means inflammation of the liver. Toxins, certain drugs, some diseases, heavy alcohol use, and bacterial and viral infections can all cause Hepatitis. Hepatitis is also the name of a family of viral infections that affect the liver; the most common types are Hepatitis A, Hepatitis B, and Hepatitis C.” (See the CDC, last updated on February 10, 2014) (2).
“Most people with chronic Hepatitis C do not have any symptoms. However, if a person has been infected for many years, his or her liver may be damaged. In many cases, there are no symptoms of the disease until liver problems have developed. In persons without symptoms, Hepatitis C is often detected during routine blood tests to measure liver function and liver enzyme (protein produced by the liver) level (2).”
“Undiagnosed hepatitis C places millions at serious risk of liver disease, cancer and death,’ Holmberg said. ‘Unfortunately, half or more of those with hepatitis C do not know they are infected.’ He said it can be 20 or 30 years between when a person is infected with the virus and when symptoms related to hepatitis C begin to appear (1).”
What can one do against the latent hepatitis C virus? The CBCD believes that Gene-Eden-VIR, developed by the biotechnology company polyDNA, might be an answer. Gene-Eden-VIR is a natural remedy that boosts the immune system against the army of sleeping (latent) hepatitis C viruses.
In regard to safety, according to polyDNA, in over three years of being on the market, there have been no reports of side effects. In addition, each bottle is GMP certified, which means that the product is keeping good manufacturing practices as outlined by the Food and Drug Administration (FDA).
"Gene-Eden combines several proven substances that work harmoniously to help boost the body’s own immune system or have other antiviral properties. The scientific data with regard to the immune enhancing and antiviral properties published in reputable sources on each individual compound in the Gene-Eden formula is impressive. Use of this product clearly has scientific merit based on published material." – Dr. Norman Cohen, MD
To see a post-marketing study, which found that Gene-Eden-VIR safely and effectively reduces hepatitis C symptoms, please visit the journal Pharmacology & Pharmacy at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.UygfI6iSz90.
To learn more about the Center for the Biology of Chronic Disease (CBCD), please visit: http://www.cbcd.net.
References:
(1) One in 100 Americans has chronic hepatitis C infection. Published on March 7, 2014.
http://www.reuters.com/article/2014/03/07/us-chronic-hepatitisc-idUSBREA261PJ20140307
(2) CDC - Hepatitis C Information for the Public. Last updated on February 10, 2014.
http://www.cdc.gov/hepatitis/c/cFAQ.htm#overview
The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.
The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.